BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1448359)

  • 1. Ovarian cancer. The most lethal gynecologic malignancy.
    Brucks JA
    Nurs Clin North Am; 1992 Dec; 27(4):835-45. PubMed ID: 1448359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for gynecologic cancer. Vulvar, vaginal, endometrial, and ovarian neoplasms.
    Hall KL; Dewar MA; Perchalski J
    Prim Care; 1992 Sep; 19(3):607-20. PubMed ID: 1410066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive look at the early detection of ovarian cancer.
    O'Rourke J; Mahon SM
    Clin J Oncol Nurs; 2003; 7(1):41-7. PubMed ID: 12629933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening and detection of ovarian cancer.
    Breedlove G; Busenhart C
    J Midwifery Womens Health; 2005; 50(1):51-4. PubMed ID: 15637515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Women's awareness of ovarian cancer risks and symptoms.
    Lockwood-Rayermann S; Donovan HS; Rambo D; Kuo CW
    Am J Nurs; 2009 Sep; 109(9):36-45; quiz 46. PubMed ID: 19704232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer.
    Baron AT; Cora EM; Lafky JM; Boardman CH; Buenafe MC; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):103-13. PubMed ID: 12582019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for ovarian cancer.
    Jacobs I; Oram D
    Biomed Pharmacother; 1988; 42(9):589-96. PubMed ID: 3071382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and screening of ovarian cancer.
    Tortolero-Luna G; Mitchell MF; Rhodes-Morris HE
    Obstet Gynecol Clin North Am; 1994 Mar; 21(1):1-23. PubMed ID: 8015758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Women and cancer.
    Knobf MT; Morra ME
    AWHONNS Clin Issues Perinat Womens Health Nurs; 1993; 4(2):287-301. PubMed ID: 8242051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for ovarian cancer: the preliminary experience of a familial ovarian cancer center.
    Muto MG; Cramer DW; Brown DL; Welch WR; Harlow BL; Xu H; Brucks JP; Tsao SW; Berkowitz RS
    Gynecol Oncol; 1993 Oct; 51(1):12-20. PubMed ID: 8244166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian intraepithelial neoplasia and ovarian cancer.
    Gershenson DM; Tortolero-Luna G; Malpica A; Baker VV; Whittaker L; Johnson E; Follen Mitchell M
    Obstet Gynecol Clin North Am; 1996 Jun; 23(2):475-543. PubMed ID: 8784888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress report on ovarian cancer screening. Scientists are making headway in detecting ovarian cancer at an earlier stage.
    Harv Womens Health Watch; 2010 Apr; 17(8):1-3. PubMed ID: 20506601
    [No Abstract]   [Full Text] [Related]  

  • 14. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
    Baron AT; Boardman CH; Lafky JM; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):306-18. PubMed ID: 15734951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Familial cancer of the ovary. A family with 6 index cases].
    de Meeus JB; Bennouna C; Maréchaud M; Plocoste V; Magnin G
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(7):749-56. PubMed ID: 8308201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian cancer of epithelial origin--an update.
    Menczer J
    Isr J Med Sci; 1993 Aug; 29(8):477-83. PubMed ID: 8407278
    [No Abstract]   [Full Text] [Related]  

  • 17. Advances in the management of epithelial ovarian cancer.
    Berkenblit A; Cannistra SA
    J Reprod Med; 2005 Jun; 50(6):426-38. PubMed ID: 16050567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimum screening interventions for gynecologic malignancies.
    Lea JS; Miller DS
    Tex Med; 2001 Feb; 97(2):49-55. PubMed ID: 11233059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospectively detected cancer in familial breast/ovarian cancer screening.
    Dørum A; Heimdal K; Løvslett K; Kristensen G; Hansen LJ; Sandvei R; Schiefloe A; Hagen B; Himmelmann A; Jerve F; Shetelig K; Fjaerestad I; Tropé C; Møller P
    Acta Obstet Gynecol Scand; 1999 Nov; 78(10):906-11. PubMed ID: 10577622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epidemiology of ovarian cancer: a review.
    Yoder LH
    Oncol Nurs Forum; 1990; 17(3):411-5. PubMed ID: 2188227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.